These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25303899)

  • 41. Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins.
    Lyly A; von Schantz C; Heine C; Schmiedt ML; Sipilä T; Jalanko A; Kyttälä A
    BMC Cell Biol; 2009 Nov; 10():83. PubMed ID: 19941651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.
    Getty AL; Pearce DA
    Cell Mol Life Sci; 2011 Feb; 68(3):453-74. PubMed ID: 20680390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs.
    Lingaas F; Aarskaug T; Sletten M; Bjerkås I; Grimholt U; Moe L; Juneja RK; Wilton AN; Galibert F; Holmes NG; Dolf G
    Anim Genet; 1998 Oct; 29(5):371-6. PubMed ID: 9800325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late infantile neuronal ceroid lipofuscinosis and dopamine deficiency.
    Le NM; Parikh S
    J Child Neurol; 2012 Feb; 27(2):234-7. PubMed ID: 21940688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Searching for interacting partners of CLN1, CLN2 and Btn1p with the two-hybrid system.
    Cottone CD; Chattopadhyay S; Pearce DA
    Eur J Paediatr Neurol; 2001; 5 Suppl A():95-8. PubMed ID: 11589016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global Brain Transcriptome Analysis of a Tpp1 Neuronal Ceroid Lipofuscinoses Mouse Model.
    Domowicz MS; Chan WC; Claudio-Vázquez P; Henry JG; Ware CB; Andrade J; Dawson G; Schwartz NB
    ASN Neuro; 2019; 11():1759091419843393. PubMed ID: 31003587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
    Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
    J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression in colorectal carcinoma of two lysosomal enzymes, CLN2 and CLN1, involved in neuronal ceroid lipofuscinosis.
    Tsukamoto T; Iida J; Dobashi Y; Furukawa T; Konishi F
    Cancer; 2006 Apr; 106(7):1489-97. PubMed ID: 16518810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
    Kyttälä A; Lahtinen U; Braulke T; Hofmann SL
    Biochim Biophys Acta; 2006 Oct; 1762(10):920-33. PubMed ID: 16839750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Developmental changes in the expression of neuronal ceroid lipofuscinoses-linked proteins.
    Suopanki J; Partanen S; Ezaki J; Baumann M; Kominami E; Tyynelä J
    Mol Genet Metab; 2000; 71(1-2):190-4. PubMed ID: 11001810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation].
    Bukina AM; Tsvetkova IV; Semiachkina AN; Il'ina ES
    Vopr Med Khim; 2002; 48(6):594-8. PubMed ID: 12698559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis.
    Cooper JD; Russell C; Mitchison HM
    Biochim Biophys Acta; 2006 Oct; 1762(10):873-89. PubMed ID: 17023146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis.
    Liu CG; Sleat DE; Donnelly RJ; Lobel P
    Genomics; 1998 Jun; 50(2):206-12. PubMed ID: 9653647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neuronal ceroid lipofuscinosis (NCL, Batten's disease)].
    Ohno K
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):486-8. PubMed ID: 11032003
    [No Abstract]   [Full Text] [Related]  

  • 58. Characterization and chromosomal mapping of a mouse ortholog of the late-infantile ceroid-lipofuscinosis gene CLN2.
    Katz ML; Liu PC; Grob-Nunn SE; Shibuya H; Johnson GS
    Mamm Genome; 1999 Nov; 10(11):1050-3. PubMed ID: 10556422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis.
    Oetjen S; Kuhl D; Hermey G
    J Neurochem; 2016 Nov; 139(3):456-470. PubMed ID: 27453211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.
    Scifo E; Szwajda A; Dębski J; Uusi-Rauva K; Kesti T; Dadlez M; Gingras AC; Tyynelä J; Baumann MH; Jalanko A; Lalowski M
    J Proteome Res; 2013 May; 12(5):2101-15. PubMed ID: 23464991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.